看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -1.4x - -1.5x | -1.4x |
| Selected Fwd EBIT Multiple | -1.2x - -1.3x | -1.2x |
| Fair Value | $1.79 - $1.87 | $1.83 |
| Upside | 53.3% - 59.8% | 56.6% |
| Benchmarks | Ticker | Full Ticker |
| Quanterix Corporation | QTRX | NasdaqGM:QTRX |
| Bio-Rad Laboratories, Inc. | BIO.B | NYSE:BIO.B |
| Nautilus Biotechnology, Inc. | NAUT | NasdaqGS:NAUT |
| Agilent Technologies, Inc. | A | NYSE:A |
| Bruker Corporation | BRKR | NasdaqGS:BRKR |
| Quantum-Si incorporated | QSI | NasdaqGM:QSI |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| QTRX | BIO.B | NAUT | A | BRKR | QSI | ||
| NasdaqGM:QTRX | NYSE:BIO.B | NasdaqGS:NAUT | NYSE:A | NasdaqGS:BRKR | NasdaqGM:QSI | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | 3.2% | NM- | 8.2% | 6.2% | NM- | |
| 3Y CAGR | NM- | -21.9% | NM- | 3.2% | -1.2% | NM- | |
| Latest Twelve Months | -21.1% | -20.4% | -7.0% | 11.0% | -16.1% | 0.3% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -48.5% | 15.5% | NA | 22.1% | 15.9% | -14853.8% | |
| Prior Fiscal Year | -33.5% | 12.6% | NA | 20.7% | 16.5% | -10066.4% | |
| Latest Fiscal Year | -36.1% | 10.5% | NA | 23.7% | 12.2% | -3550.6% | |
| Latest Twelve Months | -36.1% | 10.5% | NA | 23.5% | 12.2% | -3550.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | -0.47x | 0.86x | NA | 4.70x | 2.27x | 5.76x | |
| EV / LTM EBITDA | 1.5x | 5.2x | 0.1x | 17.0x | 12.9x | -0.2x | |
| EV / LTM EBIT | 1.3x | 8.2x | 0.1x | 20.0x | 18.7x | -0.2x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 0.1x | 8.2x | 20.0x | ||||
| Historical EV / LTM EBIT | -7.4x | -0.2x | 0.9x | ||||
| Selected EV / LTM EBIT | -1.4x | -1.4x | -1.5x | ||||
| (x) LTM EBIT | (109) | (109) | (109) | ||||
| (=) Implied Enterprise Value | 149 | 157 | 165 | ||||
| (-) Non-shareholder Claims * | 197 | 197 | 197 | ||||
| (=) Equity Value | 346 | 354 | 362 | ||||
| (/) Shares Outstanding | 183.1 | 183.1 | 183.1 | ||||
| Implied Value Range | 1.89 | 1.93 | 1.97 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 1.89 | 1.93 | 1.97 | 1.17 | |||
| Upside / (Downside) | 61.4% | 65.1% | 68.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | QTRX | BIO.B | NAUT | A | BRKR | QSI | |
| Enterprise Value | (66) | 1,996 | (83) | 30,396 | 7,736 | 18 | |
| (+) Cash & Short Term Investments | 289 | 1,665 | 130 | 1,467 | 194 | 210 | |
| (+) Investments & Other | 1 | 4,838 | 76 | 173 | 125 | 0 | |
| (-) Debt | (37) | (1,375) | (30) | (3,540) | (2,245) | (13) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | (34) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 187 | 7,124 | 93 | 28,496 | 5,775 | 214 | |
| (/) Shares Outstanding | 38.8 | 31.6 | 126.1 | 285.1 | 151.7 | 183.1 | |
| Implied Stock Price | 4.81 | 225.29 | 0.74 | 99.95 | 38.07 | 1.17 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4.81 | 225.29 | 0.74 | 99.95 | 38.07 | 1.17 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |